Author:
Dreyer Viola,Kohl Thomas A.,Niemann Stefan
Publisher
Trillium GmbH Medizinischer Fachverlag
Reference9 articles.
1. 1. Global Tuberculosis Report 2022. https://www.who.int/teams/global-tuberculosis-programme/tb-
2. reports/global-tuberculosis-report-2022
3. 2. Chedore P et al. Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Clin Microbiol 2010; 48: 300–330. https://doi.org/10.1128/JCM.01775-09
4. 3. The use of next-generation sequencing technologies for the detection of mutations associated with drug resistance in Mycobacterium tuberculosis complex: technical guide. Geneva: World Health Organization; 2018 (WHO/CDS/TB/2018.19). https://www.who.int/publications-detail-redirect/WHO-CDS-TB-2018.19
5. 4. Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance. Geneva: World Health Organization; 2021